Catalys Pacific, LLC

Est. AUM

$230.7M

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	Mineralys Therapeutics, Inc.	COM	$214.1M	7903838	92.81%	SOLE
2	Phathom Pharmaceuticals, Inc.	COM	$16.6M	1493854	7.19%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.